These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28666147)

  • 1. Sudden unexpected death in early Parkinson's disease: neurogenic or cardiac death?
    Nishida N; Yoshida K; Hata Y
    Cardiovasc Pathol; 2017; 30():19-22. PubMed ID: 28666147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
    Del Tredici K; Duda JE
    J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?
    Probst A; Bloch A; Tolnay M
    Eur J Neurol; 2008 Apr; 15 Suppl 1():1-4. PubMed ID: 18353130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
    Cersosimo MG; Benarroch EE
    J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Braak staging valid for all types of Parkinson's disease?
    Jellinger KA
    J Neural Transm (Vienna); 2019 Apr; 126(4):423-431. PubMed ID: 29943229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
    Halliday G; McCann H; Shepherd C
    Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of pathology in Parkinson's disease.
    Halliday GM; McCann H
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.
    Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T
    Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.
    Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H
    Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo gastric detection of α-synuclein inclusions in Parkinson's disease.
    Sánchez-Ferro Á; Rábano A; Catalán MJ; Rodríguez-Valcárcel FC; Fernández Díez S; Herreros-Rodríguez J; García-Cobos E; Álvarez-Santullano MM; López-Manzanares L; Mosqueira AJ; Vela Desojo L; López-Lozano JJ; López-Valdés E; Sánchez-Sánchez R; Molina-Arjona JA
    Mov Disord; 2015 Apr; 30(4):517-24. PubMed ID: 25113060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.